These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19946713)

  • 1. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant.
    Pálmason H; Moser D; Sigmund J; Vogler C; Hänig S; Schneider A; Seitz C; Marcus A; Meyer J; Freitag CM
    J Neural Transm (Vienna); 2010 Feb; 117(2):259-67. PubMed ID: 19946713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathechol-O-methyltransferase Val(158)Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD.
    Salatino-Oliveira A; Genro JP; Guimarães AP; Chazan R; Zeni C; Schmitz M; Polanczyk G; Roman T; Rohde LA; Hutz MH
    J Neural Transm (Vienna); 2012 Jun; 119(6):729-33. PubMed ID: 22270685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents.
    DeYoung CG; Getchell M; Koposov RA; Yrigollen CM; Haeffel GJ; af Klinteberg B; Oreland L; Ruchkin VV; Pakstis AJ; Grigorenko EL
    Psychiatr Genet; 2010 Feb; 20(1):20-4. PubMed ID: 19997043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk for conduct disorder symptom subtypes in an ADHD sample: specificity to aggressive symptoms.
    Monuteaux MC; Biederman J; Doyle AE; Mick E; Faraone SV
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):757-764. PubMed ID: 19465875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism.
    Qian Q; Wang Y; Zhou R; Li J; Wang B; Glatt S; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):103-9. PubMed ID: 12627475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children.
    Yatsuga C; Toyohisa D; Fujisawa TX; Nishitani S; Shinohara K; Matsuura N; Ikeda S; Muramatsu M; Hamada A; Tomoda A
    Brain Dev; 2014 Aug; 36(7):620-5. PubMed ID: 24035255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD).
    Turic D; Williams H; Langley K; Owen M; Thapar A; O'Donovan MC
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):64-7. PubMed ID: 15635644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults.
    Halleland H; Lundervold AJ; Halmøy A; Haavik J; Johansson S
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):403-10. PubMed ID: 18802928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder.
    Thapar A; Langley K; Fowler T; Rice F; Turic D; Whittinger N; Aggleton J; Van den Bree M; Owen M; O'Donovan M
    Arch Gen Psychiatry; 2005 Nov; 62(11):1275-8. PubMed ID: 16275815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
    J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal risk factors interacting with catechol O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD.
    Nijmeijer JS; Hartman CA; Rommelse NN; Altink ME; Buschgens CJ; Fliers EA; Franke B; Minderaa RB; Ormel J; Sergeant JA; Verhulst FC; Buitelaar JK; Hoekstra PJ
    J Child Psychol Psychiatry; 2010 Nov; 51(11):1242-50. PubMed ID: 20868372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample.
    Hawi Z; Millar N; Daly G; Fitzgerald M; Gill M
    Am J Med Genet; 2000 Jun; 96(3):282-4. PubMed ID: 10898900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
    Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
    J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.
    Bellgrove MA; Domschke K; Hawi Z; Kirley A; Mullins C; Robertson IH; Gill M
    Exp Brain Res; 2005 Jun; 163(3):352-60. PubMed ID: 15654584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder.
    Caspi A; Langley K; Milne B; Moffitt TE; O'Donovan M; Owen MJ; Polo Tomas M; Poulton R; Rutter M; Taylor A; Williams B; Thapar A
    Arch Gen Psychiatry; 2008 Feb; 65(2):203-10. PubMed ID: 18250258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.
    Cheon KA; Jun JY; Cho DY
    Int Clin Psychopharmacol; 2008 Sep; 23(5):291-8. PubMed ID: 18703939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD.
    Taerk E; Grizenko N; Ben Amor L; Lageix P; Mbekou V; Deguzman R; Torkaman-Zehi A; Ter Stepanian M; Baron C; Joober R
    BMC Med Genet; 2004 Dec; 5():30. PubMed ID: 15613245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN; Ruan LM; Le YP; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.